[New toxicity of fotemustine: diffuse interstitial lung disease]
M Bertrand1, L Wémeau-Stervinou, S Gauthier
1Service de dermatologie, hôpital Claude-Huriez, CHRU de Lille, rue Michel-Polonovski, 59037 Lille cedex, France.
Annales De Dermatologie Et De Venereologie
|April 10, 2012
Summary
Fotemustine, a nitrosourea drug for melanoma, can cause interstitial lung disease. This case highlights the importance of considering drug-induced lung toxicity in patients with respiratory symptoms during fotemustine treatment.
Area of Science:
- Oncology
- Pulmonology
- Pharmacology
Background:
- Fotemustine is a nitrosourea alkylating agent used for metastatic malignant melanoma.
- Nitrosourea agents are known for potential adverse effects, including pulmonary toxicity.
Observation:
- An 81-year-old male developed acute interstitial lung disease 20 days after his fourth fotemustine course.
- The patient's lung condition resolved spontaneously after fotemustine withdrawal.
- Other causes of interstitial lung disease were excluded.
Findings:
- This case presents the first instance of interstitial lung disease attributed to fotemustine monotherapy.
- Fotemustine-induced lung toxicity is a potential adverse event in melanoma treatment.
Implications:
- Clinicians should consider fotemustine as a cause of interstitial lung disease in melanoma patients presenting with respiratory symptoms.
- Early recognition and withdrawal of fotemustine may lead to spontaneous resolution of lung toxicity.
- This finding expands the known side effect profile of fotemustine and other nitrosoureas.
Related Concept Videos
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...